Federal contract award

HHSO100201100008C

HEYLTEX CORPORATION BASE YEAR FUNDING FOR R D OF PEDIATRIC PRUSSIAN BLUE CAN 1992002

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS325414 — Biological Product (except Diagnostic) Manufacturing
PSCAN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$17.2M
Current contract value$20.2M
Potential contract value / ceiling$20.2M
Start dateFeb 24, 2011
Current end dateMay 14, 2021
Potential end dateMay 14, 2021
Latest award activityJul 20, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 25 of 25 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 20, 2026P00024$-234.2KMODIFICATION P00024 IS TO DEOBLIGATE THE REMAINING FUNDS AND CLOSE THE ORDER.
Apr 28, 2021P00023$0R&D FOR SATISFACTORY METHOD OF PEDIATRIC PRUSSIAN BLUE
Nov 18, 2020P00022$554.6KR&D FOR SATISFACTORY METHOD OF PEDIATRIC PRUSSIAN BLUE
Aug 31, 2020P00021$306.3KR&D FOR SATISFACTORY METHOD OF PEDIATRIC PRUSSIAN BLUE
Jan 30, 2020P00020$0R&D FOR SATISFACTORY METHOD OF PEDIATRIC PRUSSIAN BLUE
Feb 15, 201919$0DE-OBLIGATE EXPIRING FUNDS
Sep 13, 201818$-337.6KDE-OBLIGATE EXPIRING FUNDS
Aug 27, 201817$0NCE - NO COST EXTENSION
Feb 6, 201816$0NCE - NO COST EXTENSION
Aug 17, 201715$-8.7KDE-OBLIGATE EXPIRING FUNDS
Jun 10, 201614$2.5MTHE PURPOSE OF THIS MODIFICATION IS TO (1)REVISE THE STATEMENT OF WORK; (2) PROVIDE ADDITIONAL FUNDING; AND (3)ARTICLES B.1, B.2. F.1. AND SECTION J ATTACHMENTS #1 AND #8.
Feb 26, 201613$0THE PURPOSE OF THIS MODIFICATION IS TO (1)EXTEND THE PERIOD OF PERFORMANCE OF OPTION FOUR FROM SEPTEMBER 30, 2015 THROUGH FEBRUARY 29, 2016, WITHOUT ADDITIONAL COST TO THE GOVERNMENT; (2) GIVE CONSENT AND PROVIDE FUNDING FOR SUBCONTRACTING; (3) TO INCREASE AND CORRECT THE ESTIMATED TOTAL CONTRACT VALUE.
Sep 23, 201512$337.7KTHE PURPOSE OF THIS MODIFICATION IS TO (1)EXTEND THE PERIOD OF PERFORMANCE OF OPTION FOUR FROM SEPTEMBER 30, 2015 THROUGH FEBRUARY 29, 2016, WITHOUT ADDITIONAL COST TO THE GOVERNMENT; (2) GIVE CONSENT AND PROVIDE FUNDING FOR SUBCONTRACTING; (3) TO INCREASE AND CORRECT THE ESTIMATED TOTAL CONTRACT VALUE.
Jul 16, 201511$0THE PURPOSE OF THIS MODIFICATION IS TO MODIFY ARTICLE G.3. KEY PERSONNEL. THE CONTRACT VALUE, FUNDING AND PERIOD OF PERFORMANCE REMAINS UNCHANGED.
Apr 30, 201510$3.0MTHE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION FIVE. THE PERIOD OF PERFORMANCE FOR OPTION FIVE WILL BE MAY 4, 2015 THROUGH APRIL 6, 2018.
Feb 20, 20159$0THE PURPOSE OF THIS MODIFICATION IS TO (1) REVISE THE STATEMENT OF WORK; AND (2) EXTEND THE PERIOD OF PERFORMANCE OF OPTION FOUR FROM FEBRUARY 23, 2015 THROUGH SEPTEMBER 30, 2015, WITHOUT ADDITIONAL COST TO THE GOVERNMENT.
Dec 12, 20148$0THE PURPOSE OF THIS MODIFICATION IS TO MODIFY ARTICLE G.4. VOUCHER SUBMISSION. THE CONTRACT OBLIGATED AMOUNT, VALUE AND PERIOD OF PERFORMANCE REMAINS UNCHANGED.
Nov 7, 20147$0THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE OF OPTION FOUR FROM NOVEMBER 7, 2014 TO FEBRUARY 23, 2015 WITHOUT ADDITIONAL COST TO THE GOVERNMENT.
Sep 15, 20146$0THE PURPOSE OF THIS MODIFICATION IS TO MODIFY KEY PERSONNEL. THE PERIOD OF PERFORMANCE REMAINS UNCHANGED.
May 6, 20135$5.6MEXERCISE OF OPTION 4 (CLIN 5) OF THE CONTRACT WITH CHANGES STATEMENT OF WORK, BUDGET, AND PERFORMANCE PERIOD.
Apr 8, 20134$0HEYLTEX CORPORATION BASE YEAR FUNDING FOR R D OF PEDIATRIC PRUSSIAN BLUE CAN 1992002
Mar 4, 20133$0NO COST EXTENSION OF CONTRACT PERFORMANCE PERIOD
Mar 7, 20122$5.5MHEYLTEX CORPORATION BASE YEAR FUNDING FOR R D OF PEDIATRIC PRUSSIAN BLUE CAN 1992002
Feb 22, 20121$0HEYLTEX CORPORATION BASE YEAR FUNDING FOR R D OF PEDIATRIC PRUSSIAN BLUE CAN 1992002
Feb 24, 20110$0HEYLTEX CORPORATION BASE YEAR FUNDING FOR R D OF PEDIATRIC PRUSSIAN BLUE CAN 1992002

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.